Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

p53 mutational signature of aristolochic acid in the upper urinary tract carcinomas (CROSBI ID 573824)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa

Brdar, Branko ; Slade, Neda ; Jelaković, Bojan ; Moriya, Masaaki ; Medverec, Zvonimir ; Tomic, Karla ; Karanović, Sandra ; Vuković Lela, Ivana ; Nikolić, Jovan ; Grollman, Arthur P. p53 mutational signature of aristolochic acid in the upper urinary tract carcinomas // HDIR-1 First Meeting with International Participation “From Bench to Clinic” / Sabol, Maja ; Levanat, Sonja (ur.). Zagreb: Institut Ruđer Bošković, 2010. str. 51-51

Podaci o odgovornosti

Brdar, Branko ; Slade, Neda ; Jelaković, Bojan ; Moriya, Masaaki ; Medverec, Zvonimir ; Tomic, Karla ; Karanović, Sandra ; Vuković Lela, Ivana ; Nikolić, Jovan ; Grollman, Arthur P.

engleski

p53 mutational signature of aristolochic acid in the upper urinary tract carcinomas

Endemic (Balkan) nephropathy (EN), a chronic renal disease affecting residents of rural villages situated near tributaries of Danube river, is strongly associated with cancers of the upper urinary tract (UUC). Hypothesis: (i) Dietary ingestion of aristolochic acid (AA), which after metabolic activation forms covalent DNA adducts in renal cortex and urothelial tissues, accounts, in conjunction with individual genetic susceptibility, for all epidemiologic and clinical features of EN/UUC ; (ii) Aristolactam-DNA adducts generate unique mutational spectra in p53 tumor suppressor gene, which together with the presence of DNA adducts in the renal cortex serve as biomarkers for aristolochic acid nephropathy and associated urothelial carcinomas. Methods: DNA was obtained from renal cortex and urothelial tumor tissues following nephroureterectomy of patients with EN/UUC. Aristolactam-DNA adducts were quantified in renal cortex by 32P-post-labeling techniques. Chip-sequencing technology was used to detect base substitutions in the p53 gene in urothelial tumor tissues. Results: (i) Aristolactam-DNA adducts were detected in the renal cortex where persist for extended period of time (up to 50 years) ;

aristolochic acid; TP53; signature mutation; urothelial cancer; Balkan endemic nephropathy

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

51-51.

2010.

objavljeno

Podaci o matičnoj publikaciji

HDIR-1 First Meeting with International Participation “From Bench to Clinic”

Sabol, Maja ; Levanat, Sonja

Zagreb: Institut Ruđer Bošković

978-953-6690-86-2

Podaci o skupu

HDIR-1 First Meeting with International Participation “From Bench to Clinic”

poster

11.11.2010-11.11.2010

Zagreb, Hrvatska

Povezanost rada

Temeljne medicinske znanosti, Biologija